Biofrontera (BFRI) Return on Invested Capital (2022 - 2025)

Biofrontera's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.11% for Q1 2025.

• In Q1 2025, Return on Invested Capital fell 9.0% year-over-year to 0.11%; the TTM figure through Mar 2025 stood at 0.11% (down 9.0% YoY), while the FY2023 annual figure was 0.04%, changed 0.0% from the prior year.
• Return on Invested Capital for Q1 2025 stood at 0.11%, down from 0.04% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.01% in Q2 2023, with the low at 0.11% in Q1 2025.
• The 4-year median for Return on Invested Capital is 0.02% (2024), against an average of 0.04%.
• The sharpest annual moves came in 2023 and 2025: Return on Invested Capital grew 7 bps in 2023, then dropped 9 bps in 2025.
• Biofrontera's Return on Invested Capital stood at 0.02% in 2022, then soared by 32 bps to 0.02% in 2023, then tumbled by 133 bps to 0.04% in 2024, then sank by 196 bps to 0.11% in 2025.
• Business Quant data shows BFRI's Return on Invested Capital at 0.11% in Q1 2025, 0.04% in Q4 2024, and 0.03% in Q3 2024.